$ONC
BeiGene, Ltd.

2020 Q4 Form 10-Q Financial Statement

#000165130820000208 Filed on November 05, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q4
Revenue $100.1M $91.08M $56.89M
YoY Change 75.95% 81.65% -3.03%
Cost Of Revenue $151.9M $21.12M
YoY Change 5.06%
Gross Profit $509.6M $69.96M
YoY Change 132.92%
Gross Profit Margin 509.13% 76.81%
Selling, General & Admin $1.369B $160.8M
YoY Change 53.18%
% of Gross Profit 268.53% 229.91%
Research & Development $2.177B $349.1M
YoY Change 47.31%
% of Gross Profit 427.23% 498.98%
Depreciation & Amortization $178.0M $8.157M
YoY Change 121.0%
% of Gross Profit 34.92% 11.66%
Operating Expenses $3.716B $509.9M
YoY Change 49.11%
Operating Profit -$484.9M -$440.1M -$388.0M
YoY Change 24.97% 40.95% 38.19%
Interest Expense $7.476M $185.4M
YoY Change
% of Operating Profit
Other Income/Expense, Net -$173.0K $5.711M
YoY Change -414.31%
Pretax Income -$3.199B -$435.0M
YoY Change 39.49%
Income Tax $80.33M -$8.423M
% Of Pretax Income
Net Earnings -$472.7M -$425.2M -$388.1M
YoY Change 21.82% 38.35% 44.66%
Net Earnings / Revenue -472.27% -466.87% -682.1%
Basic Earnings Per Share -$0.37
Diluted Earnings Per Share -$2.457M -$6.071M
COMMON SHARES
Basic Shares Outstanding 1.183B shares 1.149B shares 788.3M shares
Diluted Shares Outstanding 1.149B shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.651B $4.719B $982.7M
YoY Change 373.24% -44.83%
Cash & Equivalents $1.382B $1.464B $618.0M
Short-Term Investments $3.269B $3.254B $364.7M
Other Short-Term Assets $11.67M
YoY Change
Inventory $89.29M $35.53M $28.55M
Prepaid Expenses
Receivables $60.40M $60.27M $70.88M
Other Receivables $12.65M $0.00
Total Short-Term Assets $4.961B $4.966B $1.173B
YoY Change 323.02% 245.91% -39.67%
LONG-TERM ASSETS
Property, Plant & Equipment $357.7M $291.2M $242.4M
YoY Change 47.56% 28.57% 54.34%
Goodwill $109.0K $109.0K $109.0K
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $36.76M $0.00
YoY Change
Other Assets $113.1M $162.6M $68.46M
YoY Change 65.2% 150.74% 27.29%
Total Long-Term Assets $640.1M $600.7M $439.6M
YoY Change 45.6% 34.82% 43.73%
TOTAL ASSETS
Total Short-Term Assets $4.961B $4.966B $1.173B
Total Long-Term Assets $640.1M $600.7M $439.6M
Total Assets $5.601B $5.566B $1.612B
YoY Change 247.38% 195.92% -28.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $232.0M $146.3M $122.5M
YoY Change 89.37% 30.27% 8.13%
Accrued Expenses $346.1M $279.3M $163.6M
YoY Change 111.64% 62.88%
Deferred Revenue $0.00 $0.00
YoY Change -100.0%
Short-Term Debt $335.0M $0.00
YoY Change
Long-Term Debt Due 2.186B CNies $50.22M 0.000 CNies
YoY Change 7074.57% -100.0%
Total Short-Term Liabilities $1.075B $645.7M $310.3M
YoY Change 246.49% 143.0% 25.91%
LONG-TERM LIABILITIES
Long-Term Debt 1.198B CNies $151.6M 580.0M CNies
YoY Change 106.59% 45.4% 1322.09%
Other Long-Term Liabilities $57.43M $47.89M $46.56M
YoY Change 23.34% 30.92% -4.53%
Total Long-Term Liabilities $656.3M $624.2M $323.6M
YoY Change 102.8% 94.38% 29.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.075B $645.7M $310.3M
Total Long-Term Liabilities $656.3M $624.2M $323.6M
Total Liabilities $1.732B $1.270B $633.9M
YoY Change 173.14% 116.39% 27.8%
SHAREHOLDERS EQUITY
Retained Earnings -$3.553B -$3.080B -$1.956B
YoY Change 81.65% 96.46% 94.18%
Common Stock $118.0K $118.0K $79.00K
YoY Change 49.37% 51.28% 2.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.869B $4.287B $962.2M
YoY Change
Total Liabilities & Shareholders Equity $5.601B $5.566B $1.612B
YoY Change 247.38% 195.92% -28.33%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q4
OPERATING ACTIVITIES
Net Income -$472.7M -$425.2M -$388.1M
YoY Change 21.82% 38.35% 44.66%
Depreciation, Depletion And Amortization $178.0M $8.157M
YoY Change 121.0%
Cash From Operating Activities -$2.424B -$2.755B
YoY Change
INVESTING ACTIVITIES
Capital Expenditures -$298.2M -$693.9M
YoY Change
Acquisitions
YoY Change
Other Investing Activities $487.6M -$21.35B
YoY Change
Cash From Investing Activities $189.4M -$22.05B
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.147B 29.22B
YoY Change
NET CHANGE
Cash From Operating Activities -2.424B -2.755B
Cash From Investing Activities 189.4M -22.05B
Cash From Financing Activities 2.147B 29.22B
Net Change In Cash -87.77M 4.422B
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$2.424B -$2.755B
Capital Expenditures -$298.2M -$693.9M
Free Cash Flow -$2.126B -$2.061B
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Central Index Key
EntityCentralIndexKey
0001651308
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37686
dei Entity Registrant Name
EntityRegistrantName
BEIGENE, LTD.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1209416
dei Entity Address Address Line1
EntityAddressAddressLine1
c/o Mourant Governance Services (Cayman) Limited
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1182916659 shares
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Address Address Line2
EntityAddressAddressLine2
94 Solaris Avenue, Camana Bay
dei Entity Address City Or Town
EntityAddressCityOrTown
Grand Cayman
dei Entity Address Country
EntityAddressCountry
KY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
KY1-1108
dei City Area Code
CityAreaCode
345
dei Local Phone Number
LocalPhoneNumber
949-4123
dei Security12b Title
Security12bTitle
American Depositary Shares, each representing 13 Ordinary Shares, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
BGNE
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1464470000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
618011000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
295000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
288000 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
3254300000 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
364728000 USD
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
60266000 USD
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
70878000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
35525000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
28553000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
150880000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
90238000 USD
CY2020Q3 us-gaap Assets Current
AssetsCurrent
4965736000 USD
CY2019Q4 us-gaap Assets Current
AssetsCurrent
1172696000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4950000 USD
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
2476000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
291218000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
242402000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
88689000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
82520000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5188000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5846000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
48009000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
37894000 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
162600000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
68455000 USD
CY2020Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
600654000 USD
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
439593000 USD
CY2020Q3 us-gaap Assets
Assets
5566390000 USD
CY2019Q4 us-gaap Assets
Assets
1612289000 USD
CY2020Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
146265000 USD
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
122488000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
279323000 USD
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
25833000 USD
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
11884000 USD
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
10532000 USD
CY2020Q3 bgne Research And Development Cost Share Liability Noncurrent Portion
ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion
384151000 USD
CY2019Q4 bgne Research And Development Cost Share Liability Noncurrent Portion
ResearchAndDevelopmentCostShareLiabilityNoncurrentPortion
0 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
47890000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
46562000 USD
CY2020Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
624155000 USD
CY2019Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
323622000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
163556000 USD
CY2020Q3 us-gaap Taxes Payable Current
TaxesPayableCurrent
9244000 USD
CY2019Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
13454000 USD
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
13280000 USD
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
10814000 USD
CY2020Q3 bgne Research And Development Cost Share Liability Current Portion
ResearchAndDevelopmentCostShareLiabilityCurrentPortion
147387000 USD
CY2019Q4 bgne Research And Development Cost Share Liability Current Portion
ResearchAndDevelopmentCostShareLiabilityCurrentPortion
0 USD
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
50222000 USD
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 USD
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
645721000 USD
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
310312000 USD
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
151551000 USD
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
83311000 USD
CY2020Q3 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
0 USD
CY2019Q4 us-gaap Due To Related Parties Noncurrent
DueToRelatedPartiesNoncurrent
157384000 USD
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
28679000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
633934000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
1269876000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
9500000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1182916659 shares
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1182916659 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
801340698 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
801340698 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
118000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
79000 USD
CY2020Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7367799000 USD
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
2925970000 USD
CY2020Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-419000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8001000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3080004000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1955843000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
4287494000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
962205000 USD
CY2020Q3 us-gaap Minority Interest
MinorityInterest
9020000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
16150000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4296514000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
978355000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5566390000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1612289000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91080000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50141000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
208774000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
371320000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
21123000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
20106000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
49579000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
53206000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
349070000 USD
CY2019Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
236968000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
939340000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
644079000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
160837000 USD
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
105002000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
391967000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
244895000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
187000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
331000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
658000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
994000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
531217000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
362407000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1381544000 USD
us-gaap Costs And Expenses
CostsAndExpenses
943174000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-440137000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-312266000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-1172770000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-571854000 USD
CY2020Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-614000 USD
CY2019Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
2206000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
7184000 USD
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
9569000 USD
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5711000 USD
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1817000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29368000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-967000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-435040000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-311877000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1136218000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-563252000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8423000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3217000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8344000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-569000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-426617000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-308660000 USD
us-gaap Profit Loss
ProfitLoss
-1127874000 USD
us-gaap Profit Loss
ProfitLoss
-562683000 USD
CY2020Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1393000 USD
CY2019Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1303000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-3713000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2116000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-425224000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-307357000 USD
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
781482459 shares
us-gaap Net Income Loss
NetIncomeLoss
-1124161000 USD
us-gaap Net Income Loss
NetIncomeLoss
-560567000 USD
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.72
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1148973077 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1052940583 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
777938599 shares
CY2020Q3 bgne Earnings Per American Depository Share
EarningsPerAmericanDepositoryShare
-4.81
CY2019Q3 bgne Earnings Per American Depository Share
EarningsPerAmericanDepositoryShare
-5.11
bgne Earnings Per American Depository Share
EarningsPerAmericanDepositoryShare
-13.88
bgne Earnings Per American Depository Share
EarningsPerAmericanDepositoryShare
-9.37
CY2020Q3 bgne Weighted Average Number Of American Depository Shares Outstanding
WeightedAverageNumberOfAmericanDepositorySharesOutstanding
88382544 shares
CY2019Q3 bgne Weighted Average Number Of American Depository Shares Outstanding
WeightedAverageNumberOfAmericanDepositorySharesOutstanding
60114035 shares
bgne Weighted Average Number Of American Depository Shares Outstanding
WeightedAverageNumberOfAmericanDepositorySharesOutstanding
80995429 shares
bgne Weighted Average Number Of American Depository Shares Outstanding
WeightedAverageNumberOfAmericanDepositorySharesOutstanding
59841431 shares
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-426617000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-308660000 USD
us-gaap Profit Loss
ProfitLoss
-1127874000 USD
us-gaap Profit Loss
ProfitLoss
-562683000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
10143000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-13670000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
7526000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-17252000 USD
CY2020Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1044000 USD
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1260000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
184000 USD
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
326000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-417518000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-323590000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1120164000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-579609000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1174000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1628000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-3585000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-2686000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-416344000 USD
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-321962000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1116579000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-576923000 USD
us-gaap Profit Loss
ProfitLoss
-1127874000 USD
us-gaap Profit Loss
ProfitLoss
-562683000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
23961000 USD
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
11133000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
134020000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
95812000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
9974000 USD
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
0 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
11307000 USD
us-gaap Deconsolidation Gain Or Loss Amount
DeconsolidationGainOrLossAmount
0 USD
bgne Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
89500000 USD
bgne Acquired In Process Research And Development
AcquiredInProcessResearchAndDevelopment
49000000 USD
bgne Amortizationof Research And Development Financing Liability
AmortizationofResearchAndDevelopmentFinancingLiability
-85296000 USD
bgne Amortizationof Research And Development Financing Liability
AmortizationofResearchAndDevelopmentFinancingLiability
0 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-8762000 USD
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-13334000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
1144000 USD
us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-2733000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-10497000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
14856000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6972000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
21270000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
52941000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5653000 USD
bgne Increase Decrease In Operating Lease Rightof Use Asset
IncreaseDecreaseInOperatingLeaseRightofUseAsset
5207000 USD
bgne Increase Decrease In Operating Lease Rightof Use Asset
IncreaseDecreaseInOperatingLeaseRightofUseAsset
4303000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
5980000 USD
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
15307000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
21979000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8151000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
115872000 USD
us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
33494000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-12272000 USD
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
3173000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-27982000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
5312000 USD
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
2072000 USD
bgne Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-26827000 USD
bgne Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1500000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-951127000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-483088000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
82819000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
74148000 USD
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
2025000 USD
us-gaap Cash Divested From Deconsolidation
CashDivestedFromDeconsolidation
0 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
4879705000 USD
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
850825000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1972608000 USD
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
1552028000 USD
bgne Payments To Purchase In Process Research And Development
PaymentsToPurchaseInProcessResearchAndDevelopment
89500000 USD
bgne Payments To Purchase In Process Research And Development
PaymentsToPurchaseInProcessResearchAndDevelopment
49000000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3081441000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
578055000 USD
bgne Proceeds From Issuance Of Common Stock Net Of Underwriter Discount
ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount
4232017000 USD
bgne Proceeds From Issuance Of Common Stock Net Of Underwriter Discount
ProceedsFromIssuanceOfCommonStockNetOfUnderwriterDiscount
0 USD
bgne Proceeds From Research And Development Financing Liability
ProceedsFromResearchAndDevelopmentFinancingLiability
616834000 USD
bgne Proceeds From Research And Development Financing Liability
ProceedsFromResearchAndDevelopmentFinancingLiability
0 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
4000000 USD
bgne Payments To Acquire Interest In Joint Venture Financing Activities
PaymentsToAcquireInterestInJointVentureFinancingActivities
28723000 USD
bgne Payments To Acquire Interest In Joint Venture Financing Activities
PaymentsToAcquireInterestInJointVentureFinancingActivities
0 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
64288000 USD
us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
67489000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
132061000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
8394000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
48983000 USD
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
0 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
75830000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
20387000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4877168000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
83482000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4340000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-18339000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
848940000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
160110000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
620775000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
740713000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1469715000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
900823000 USD
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1464470000 USD
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
856851000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
295000 USD
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
14271000 USD
CY2020Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4950000 USD
CY2019Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
30401000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
10596000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
8951000 USD
us-gaap Interest Paid Net
InterestPaidNet
41577000 USD
us-gaap Interest Paid Net
InterestPaidNet
3335000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
30926000 USD
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
29255000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
978355000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2162407000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11629000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
38255000 USD
CY2020Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1349000 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-364939000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2827056000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
16569000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
45468000 USD
CY2020Q2 us-gaap Noncontrolling Interest Decrease From Deconsolidation
NoncontrollingInterestDecreaseFromDeconsolidation
3545000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2738000 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-336318000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2546492000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2069610000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
47632000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
50297000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
9099000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-426617000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4296514000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1753647000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6269000 USD
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
26392000 USD
CY2019Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
4440000 USD
CY2019Q1 us-gaap Profit Loss
ProfitLoss
-168069000 USD
CY2019Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1622679000 USD
CY2019Q2 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
4000000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4373000 USD
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
32602000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-6436000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
-85954000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1571264000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9745000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
36818000 USD
CY2019Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-14930000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
-308660000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1294237000 USD
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of estimates</span></div><div style="margin-bottom:9pt;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of the unaudited interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the period. Areas where management uses subjective judgment include, but are not limited to, estimating the useful lives of long-lived assets, estimating variable consideration in product sales and collaboration revenue arrangements, identifying separate accounting units and the standalone selling price of each performance obligation in the Company’s revenue arrangements, estimating the fair value of net assets acquired in business combinations, assessing the impairment of long-lived assets, valuation and recognition of share-based compensation expenses, realizability of deferred tax assets, estimating uncertain tax positions, measurement of right-of-use assets and lease liabilities and the fair value of financial instruments. Management bases the estimates on historical experience, known trends and various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from these estimates.</span></div>
CY2020Q3 bgne Reimbursement Expense
ReimbursementExpense
4629000 USD
bgne Reimbursement Expense
ReimbursementExpense
4629000 USD
CY2020Q3 bgne Upfront Payments For Collaboration
UpfrontPaymentsForCollaboration
66500000 USD
CY2019Q3 bgne Upfront Payments For Collaboration
UpfrontPaymentsForCollaboration
0 USD
bgne Upfront Payments For Collaboration
UpfrontPaymentsForCollaboration
109500000 USD
bgne Upfront Payments For Collaboration
UpfrontPaymentsForCollaboration
30000000 USD
CY2020Q3 bgne Milestone Payments
MilestonePayments
1000000 USD
CY2019Q3 bgne Milestone Payments
MilestonePayments
0 USD
bgne Milestone Payments
MilestonePayments
6000000 USD
bgne Milestone Payments
MilestonePayments
0 USD
CY2020Q3 bgne Upfront And Milestone Payments
UpfrontAndMilestonePayments
67500000 USD
CY2019Q3 bgne Upfront And Milestone Payments
UpfrontAndMilestonePayments
0 USD
bgne Upfront And Milestone Payments
UpfrontAndMilestonePayments
115500000 USD
bgne Upfront And Milestone Payments
UpfrontAndMilestonePayments
30000000 USD
CY2020Q3 us-gaap Restricted Cash
RestrictedCash
5245000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
3252873000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1427000 USD
CY2020Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2020Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
3254300000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
363440000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1288000 USD
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
0 USD
CY2019Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
364728000 USD
CY2020Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1235000 USD
CY2019Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
0 USD
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
0 USD
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
0 USD
CY2020Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
34290000 USD
CY2019Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
28553000 USD
CY2020Q3 us-gaap Inventory Net
InventoryNet
35525000 USD
CY2019Q4 us-gaap Inventory Net
InventoryNet
28553000 USD
CY2020Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
292090000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
258156000 USD
CY2020Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
61443000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
36709000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
291218000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
242402000 USD
CY2020Q3 us-gaap Depreciation
Depreciation
8157000 USD
us-gaap Depreciation
Depreciation
23303000 USD
CY2019Q3 us-gaap Depreciation
Depreciation
3691000 USD
us-gaap Depreciation
Depreciation
10139000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8316000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3128000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5188000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8316000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
2470000 USD
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5846000 USD
CY2020Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
187000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
658000 USD
CY2019Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
331000 USD
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
994000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
188000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
750000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
750000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
750000 USD
CY2020Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
750000 USD
CY2020Q3 bgne Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
2000000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8423000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-8344000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3217000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-569000 USD
CY2020Q3 us-gaap Income Tax Receivable
IncomeTaxReceivable
5586000 USD
CY2020Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
6542000 USD
CY2020Q3 bgne Unrecognized Tax Benefits Increase Resulting From Tax Credit And Incentives
UnrecognizedTaxBenefitsIncreaseResultingFromTaxCreditAndIncentives
759000 USD
bgne Unrecognized Tax Benefits Increase Resulting From Tax Credit And Incentives
UnrecognizedTaxBenefitsIncreaseResultingFromTaxCreditAndIncentives
1909000 USD
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
114000 USD
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 USD
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
0 USD
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
114000 USD
CY2020Q3 bgne Prepaid Research And Development Costs
PrepaidResearchAndDevelopmentCosts
76498000 USD
CY2019Q4 bgne Prepaid Research And Development Costs
PrepaidResearchAndDevelopmentCosts
65886000 USD
CY2020Q3 us-gaap Prepaid Taxes
PrepaidTaxes
14192000 USD
CY2019Q4 us-gaap Prepaid Taxes
PrepaidTaxes
9498000 USD
CY2020Q3 bgne Payroll Tax Receivable Current
PayrollTaxReceivableCurrent
13537000 USD
CY2019Q4 bgne Payroll Tax Receivable Current
PayrollTaxReceivableCurrent
5365000 USD
CY2020Q3 us-gaap Interest Receivable Current
InterestReceivableCurrent
5792000 USD
CY2019Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
1932000 USD
CY2020Q3 us-gaap Prepaid Insurance
PrepaidInsurance
3775000 USD
CY2019Q4 us-gaap Prepaid Insurance
PrepaidInsurance
711000 USD
CY2020Q3 bgne Prepaid Manufacturing Costs
PrepaidManufacturingCosts
22136000 USD
CY2019Q4 bgne Prepaid Manufacturing Costs
PrepaidManufacturingCosts
3829000 USD
CY2020Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
8062000 USD
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0 USD
CY2020Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
6888000 USD
CY2019Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
3017000 USD
CY2020Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
150880000 USD
CY2019Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
90238000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
109000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
109000 USD
CY2020Q3 bgne Prepayment Of Long Term Asset
PrepaymentOfLongTermAsset
32931000 USD
CY2019Q4 bgne Prepayment Of Long Term Asset
PrepaymentOfLongTermAsset
10289000 USD
CY2020Q3 bgne Prepaid Construction Cost
PrepaidConstructionCost
30366000 USD
CY2019Q4 bgne Prepaid Construction Cost
PrepaidConstructionCost
24881000 USD
CY2020Q3 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
29413000 USD
CY2019Q4 us-gaap Value Added Tax Receivable Noncurrent
ValueAddedTaxReceivableNoncurrent
29967000 USD
CY2020Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
28723000 USD
CY2019Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 USD
CY2020Q3 bgne Rental Deposits And Other
RentalDepositsAndOther
4302000 USD
CY2019Q4 bgne Rental Deposits And Other
RentalDepositsAndOther
3209000 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
36756000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
0 USD
CY2020Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
162600000 USD
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
68455000 USD
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
71255000 USD
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
54156000 USD
CY2020Q3 bgne Accrued Liabilities External Research And Development
AccruedLiabilitiesExternalResearchAndDevelopment
139990000 USD
CY2019Q4 bgne Accrued Liabilities External Research And Development
AccruedLiabilitiesExternalResearchAndDevelopment
62794000 USD
CY2020Q3 bgne Accrued Expenses Commercial Activities
AccruedExpensesCommercialActivities
40179000 USD
CY2019Q4 bgne Accrued Expenses Commercial Activities
AccruedExpensesCommercialActivities
25645000 USD
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
19815000 USD
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
9648000 USD
CY2020Q3 bgne Accrued Sales Rebates And Returns Current
AccruedSalesRebatesAndReturnsCurrent
7524000 USD
CY2019Q4 bgne Accrued Sales Rebates And Returns Current
AccruedSalesRebatesAndReturnsCurrent
3198000 USD
CY2020Q3 bgne Accrued Professional Fees And Other Current
AccruedProfessionalFeesAndOtherCurrent
560000 USD
CY2019Q4 bgne Accrued Professional Fees And Other Current
AccruedProfessionalFeesAndOtherCurrent
8115000 USD
CY2020Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
279323000 USD
CY2019Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
163556000 USD
CY2020Q3 bgne Government Grants Or Incentives Received And Deferred Noncurrent
GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent
47720000 USD
CY2019Q4 bgne Government Grants Or Incentives Received And Deferred Noncurrent
GovernmentGrantsOrIncentivesReceivedAndDeferredNoncurrent
46391000 USD
CY2020Q3 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
170000 USD
CY2019Q4 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
171000 USD
CY2020Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
47890000 USD
CY2019Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
46562000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-425224000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-307357000 USD
us-gaap Net Income Loss
NetIncomeLoss
-1124161000 USD
us-gaap Net Income Loss
NetIncomeLoss
-560567000 USD
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1148973077 shares
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
781482459 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
1052940583 shares
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
777938599 shares
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.37
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.07
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.72
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
50297000 USD
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
36818000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
134020000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
95812000 USD
CY2020Q3 bgne Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage
RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage
0.10
CY2020Q3 bgne Restricted Net Assets Minimum Required Statutory Reserve Of Annual After Tax Profit Percentage
RestrictedNetAssetsMinimumRequiredStatutoryReserveOfAnnualAfterTaxProfitPercentage
0.10
CY2020Q3 bgne Restricted Net Assets Required Statutory Reserve As Percentage Of Registered Capital
RestrictedNetAssetsRequiredStatutoryReserveAsPercentageOfRegisteredCapital
0.50
CY2020Q3 us-gaap Unrecorded Unconditional Purchase Obligation Balance Sheet Amount
UnrecordedUnconditionalPurchaseObligationBalanceSheetAmount
142858000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segment
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
91080000 USD
CY2019Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
50141000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
208774000 USD
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
371320000 USD

Files In Submission

Name View Source Status
0001651308-20-000208-index-headers.html Edgar Link pending
0001651308-20-000208-index.html Edgar Link pending
0001651308-20-000208.txt Edgar Link pending
0001651308-20-000208-xbrl.zip Edgar Link pending
bgne-20200930.htm Edgar Link pending
bgne-20200930.xsd Edgar Link pending
bgne-20200930_cal.xml Edgar Link unprocessable
bgne-20200930_def.xml Edgar Link unprocessable
bgne-20200930_htm.xml Edgar Link completed
bgne-20200930_lab.xml Edgar Link unprocessable
bgne-20200930_pre.xml Edgar Link unprocessable
exhibit311-2020q3.htm Edgar Link pending
exhibit312-2020q3.htm Edgar Link pending
exhibit321-2020q3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending